Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

516.34
+3.080.60%
Post-market: 515.00-1.3400-0.26%19:55 EDT
Volume:900.00K
Turnover:463.58M
Market Cap:131.01B
PE:30.05
High:519.07
Open:518.35
Low:510.20
Close:513.26
52wk High:560.25
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.13
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.47
PE(LYR):33.70

Loading ...

Apr 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 24, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Major Issues Report

8-K - Current report
Oct 28, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2022

Major Issues Report

8-K - Current report
Sep 26, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 04, 2022

Major Issues Report

8-K - Current report
Jul 11, 2022

Major Issues Report

8-K - Current report
Jul 05, 2022

Major Issues Report

8-K - Current report